Holen Sie sich die Stockscreener-App
22.62
2.19%
-0.7033
Schlusskurs vom Vortag:
$23.32
Offen:
$23.22
24-Stunden-Volumen:
77,073
Relative Volume:
0.09
Marktkapitalisierung:
$6.36B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.00%
1M Leistung:
+16.38%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$22.57
$23.30
1-Wochen-Bereich:
$22.74
$24.16
52-Wochen-Spanne:
$15.40
$24.43
Medifast Inc Stock (MMED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
763-222-9423
Adresse
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ROL, SCI, ANDG, HRB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MMED
Medifast Inc
|
22.59 | 6.56B | 0 | 0 | 0 | 0.00 |
ROL
Rollins Inc
|
34.64 | 16.82B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
79.47 | 11.04B | 4.33B | 535.79M | 486.05M | 3.79 |
ANDG
Andersen Group Inc
|
53.99 | 6.08B | 871.37M | -163.01M | 0 | 1.0456 |
HRB
H R Block Inc
|
45.95 | 5.66B | 3.91B | 736.10M | 760.88M | 5.6238 |
Medifast Inc Aktie (MMED) Neueste Nachrichten
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates - Eastern Progress
Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Yahoo Finance
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Yahoo Finance
MEDIFAST INC (MED) Peer Comparison – Compare with Others - Value Research
Medifast Launches the Medifast Metabolic Health Institute - Direct Selling News
MEDIFAST INC (MED) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Nigeria
Medifast (NYSE: MED) director adds 43K shares in open-market buy - Stock Titan
MEDIFAST INC (MED) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Medifast director Kiai Parsa buys $529k in MED stock - Investing.com
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™ - Yahoo Finance
Medifast director Kiai Parsa buys $51,973 of common stock - Bitget
Steamboat Capital Partners, LLC Adds to Medifast Inc (MED) Stake -- Shares Trade 46% Above GF Value - GuruFocus
MEDIFAST (MED) Financial Update: EPS Exceeds Its Estimate for the Current Session; Closing Reaction: Shares Move 0.42% Up on the DayRevenue Report - vinanet.vn
MED | Medifast, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Medifast (NYSE: MED) sees Steamboat Capital build 790,693-share stake - Stock Titan
Medifast (NYSE:MED) Director Purchases 43,150 Shares of Stock - MarketBeat
Insider Buying: Medifast (NYSE:MED) Director Acquires 29,337 Shares of Stock - MarketBeat
Medifast director Parsa Kiai acquires $842,698 in company shares By Investing.com - Investing.com Nigeria
Medifast director Parsa Kiai acquires $842,698 in company shares - Investing.com
Medifast (NYSE: MED) director buying near $11 — see how many shares he added - Stock Titan
Can Medifast's New Compensation Plan Accelerate Coach Growth? - TradingView
MEDIFAST (MED) Results Versus Estimates: EPS Beats Its Estimate; After Results: The Stock Records a 0.35% Increase - vinanet.vn
MEDIFAST (MED) Earnings Update: EPS Prints Above Forecast in the Latest Session; Closing Move - vinanet.vn
How the Needle is Moving on This Health and Wellness Stock: Medifast, Inc. - Kalkine
MEDIFAST (MED) Holds Key Support at $10.87 as Stock Edges LowerTriple EMA - vinanet.vn
Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake - Stock Titan
Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G - Stock Titan
Medifast (NYSE:MED) Cut to Hold at Zacks Research - MarketBeat
Medifast (MED): Charles Schwab Investment Management reports 3.6% ownership stake - Stock Titan
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth? - Yahoo Finance
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Medifast (MED) Q2 2026 Earnings Call Transcript - AOL.com
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround? - TradingView
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building? - TradingView
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround? - TradingView
Why Medifast (MED) Stock Is Trading Up Today - Yahoo Finance
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade) - Seeking Alpha
Medifast rebrands flagship diet product amid pressure from GLP-1s - The Business Journals
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves - finance.yahoo.com
Medifast, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... By GuruFocus - Investing.com Canada
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... - Yahoo Finance
Medifast Q2 loss widens as coach base shrinks by 48.7% - scanx.trade
Medifast Q2 Earnings Call Highlights - MarketBeat
Medifast, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:MED) 2026-08-03 - Seeking Alpha
Earnings call transcript: Medifast tops Q2 2026 estimates, shares jump after hours - Investing.com South Africa
Medifast (NYSE:MED) Updates FY 2026 Earnings Guidance - MarketBeat
Finanzdaten der Medifast Inc-Aktie (MMED)
Es liegen keine Finanzdaten für Medifast Inc (MMED) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):